H.M. Chan & Co advises key shareholder of Alibaba Health Information Technology in SFC Panel Hearing

H.M. Chan & Co has advised an executive director and substantial shareholder of Alibaba Health Information Technology Limited on the Securities and Futures Commission (SFC) Panel Hearing relating to the HK$1.3 billion takeover of CITIC 21CN Co., Ltd. by Alibaba Group and Yunfeng Capital. Working closely with Senior Counsel, Daniel Fung, of Des Voeux Chambers, the H.M. Chan & Co team comprised Mark Chan (Managing Partner), Jennifer Ng (Counsel) and Avis Lau (Associate).